106 related articles for article (PubMed ID: 7926368)
1. The paradoxical regulation of protein phosphorylation in insulin action.
Saltiel AR
FASEB J; 1994 Oct; 8(13):1034-40. PubMed ID: 7926368
[TBL] [Abstract][Full Text] [Related]
2. Diverse signaling pathways in the cellular actions of insulin.
Saltiel AR
Am J Physiol; 1996 Mar; 270(3 Pt 1):E375-85. PubMed ID: 8638681
[TBL] [Abstract][Full Text] [Related]
3. Protein phosphatase 2A negatively regulates insulin's metabolic signaling pathway by inhibiting Akt (protein kinase B) activity in 3T3-L1 adipocytes.
Ugi S; Imamura T; Maegawa H; Egawa K; Yoshizaki T; Shi K; Obata T; Ebina Y; Kashiwagi A; Olefsky JM
Mol Cell Biol; 2004 Oct; 24(19):8778-89. PubMed ID: 15367694
[TBL] [Abstract][Full Text] [Related]
4. Effects of second messengers on serine/threonine protein phosphatases in insulin-secreting cells.
Sjöholm A; Berggren PO; Honkanen RE
Biochem Biophys Res Commun; 2001 May; 283(2):364-8. PubMed ID: 11327709
[TBL] [Abstract][Full Text] [Related]
5. Insulin regulation of mitogen-activated protein kinase kinase (MEK), mitogen-activated protein kinase and casein kinase in the cell nucleus: a possible role in the regulation of gene expression.
Kim SJ; Kahn CR
Biochem J; 1997 May; 323 ( Pt 3)(Pt 3):621-7. PubMed ID: 9169593
[TBL] [Abstract][Full Text] [Related]
6. Human Protein Kinases and Obesity.
Engin A
Adv Exp Med Biol; 2017; 960():111-134. PubMed ID: 28585197
[TBL] [Abstract][Full Text] [Related]
7. Diabetes in the Goto-Kakizaki rat is accompanied by impaired insulin-mediated myosin-bound phosphatase activation and vascular smooth muscle cell relaxation.
Sandu OA; Ragolia L; Begum N
Diabetes; 2000 Dec; 49(12):2178-89. PubMed ID: 11118023
[TBL] [Abstract][Full Text] [Related]
8. Positive and negative regulation of insulin signaling through IRS-1 phosphorylation.
Gual P; Le Marchand-Brustel Y; Tanti JF
Biochimie; 2005 Jan; 87(1):99-109. PubMed ID: 15733744
[TBL] [Abstract][Full Text] [Related]
9. Phosphorylation and dephosphorylation of protein in regulating cellular function.
Kurosawa M
J Pharmacol Toxicol Methods; 1994 Jun; 31(3):135-9. PubMed ID: 8068974
[TBL] [Abstract][Full Text] [Related]
10. Identification of major ERK-related phosphorylation sites in Gab1.
Lehr S; Kotzka J; Avci H; Sickmann A; Meyer HE; Herkner A; Muller-Wieland D
Biochemistry; 2004 Sep; 43(38):12133-40. PubMed ID: 15379552
[TBL] [Abstract][Full Text] [Related]
11. Novel signal transduction pathway for luteinizing hormone and its interaction with insulin: activation of Janus kinase/signal transducer and activator of transcription and phosphoinositol 3-kinase/Akt pathways.
Carvalho CR; Carvalheira JB; Lima MH; Zimmerman SF; Caperuto LC; Amanso A; Gasparetti AL; Meneghetti V; Zimmerman LF; Velloso LA; Saad MJ
Endocrinology; 2003 Feb; 144(2):638-47. PubMed ID: 12538627
[TBL] [Abstract][Full Text] [Related]
12. Hematopoietic growth-factor signal transduction and regulation of gene expression.
Farrar WL; Brini AT; Harel-Bellan A; Korner M; Ferris DK
Immunol Ser; 1990; 49():379-410. PubMed ID: 2090258
[TBL] [Abstract][Full Text] [Related]
13. Interleukin-1alpha inhibits insulin signaling with phosphorylating insulin receptor substrate-1 on serine residues in 3T3-L1 adipocytes.
He J; Usui I; Ishizuka K; Kanatani Y; Hiratani K; Iwata M; Bukhari A; Haruta T; Sasaoka T; Kobayashi M
Mol Endocrinol; 2006 Jan; 20(1):114-24. PubMed ID: 16150868
[TBL] [Abstract][Full Text] [Related]
14. Hanks-Type Serine/Threonine Protein Kinases and Phosphatases in Bacteria: Roles in Signaling and Adaptation to Various Environments.
Janczarek M; Vinardell JM; Lipa P; Karaś M
Int J Mol Sci; 2018 Sep; 19(10):. PubMed ID: 30248937
[TBL] [Abstract][Full Text] [Related]
15. Signalling pathways of an insulin-mimetic phosphoinositolglycan-peptide in muscle and adipose tissue.
Kessler A; Müller G; Wied S; Crecelius A; Eckel J
Biochem J; 1998 Feb; 330 ( Pt 1)(Pt 1):277-86. PubMed ID: 9461521
[TBL] [Abstract][Full Text] [Related]
16. Novel Ser/Thr protein phosphatases in cell death regulation.
Sun H; Wang Y
Physiology (Bethesda); 2012 Feb; 27(1):43-52. PubMed ID: 22311969
[TBL] [Abstract][Full Text] [Related]
17. Alterations in the insulin signaling pathway induced by immortalization and H-ras transformation of brown adipocytes.
Valverde AM; Lorenzo M; Teruel T; Benito M
Endocrinology; 1997 Aug; 138(8):3195-206. PubMed ID: 9231768
[TBL] [Abstract][Full Text] [Related]
18. Selected contribution: insulin utilizes NO/cGMP pathway to activate myosin phosphatase via Rho inhibition in vascular smooth muscle.
Sandu OA; Ito M; Begum N
J Appl Physiol (1985); 2001 Sep; 91(3):1475-82. PubMed ID: 11509551
[TBL] [Abstract][Full Text] [Related]
19. The activity of calmodulin is altered by phosphorylation: modulation of calmodulin function by the site of phosphate incorporation.
Sacks DB; Mazus B; Joyal JL
Biochem J; 1995 Nov; 312 ( Pt 1)(Pt 1):197-204. PubMed ID: 7492313
[TBL] [Abstract][Full Text] [Related]
20. Regulation of myosin-bound protein phosphatase by insulin in vascular smooth muscle cells: evaluation of the role of Rho kinase and phosphatidylinositol-3-kinase-dependent signaling pathways.
Begum N; Duddy N; Sandu O; Reinzie J; Ragolia L
Mol Endocrinol; 2000 Sep; 14(9):1365-76. PubMed ID: 10976915
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
